18F-AV-1451 High Resolution Autopsy Study
| Status: | Completed |
|---|---|
| Conditions: | Alzheimer Disease |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 60 - 89 |
| Updated: | 10/26/2018 |
| Start Date: | June 2015 |
| End Date: | May 18, 2018 |
A High Resolution Autopsy Study Evaluating the Relationship of 18F-AV-1451 PET Imaging and Tau Pathology
The study is designed to examine the relationship between imaging results detected on a
18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.
18F-AV-1451 PET scan and pathology found at autopsy within six months of imaging.
Inclusion Criteria:
- Projected life expectancy ≤ 6 months
Exclusion Criteria:
- Primary brain tumor, known metastases to the brain, central nervous system lymphoma
- Major, focal structural brain lesion
- Aggressively being treated with life sustaining measures
- Clinically significant infectious disease
- History of risk factors for Torsades de Pointes or are currently taking medication
known to cause QT prolongation
- Have received or participated in a trial with investigational medications in the past
30 days
- Females of childbearing potential who are pregnant or not using adequate contraception
We found this trial at
2
sites
San Francisco, California 94143
Principal Investigator: Duygu Tosun-Turgut
Phone: 415-221-4810
Click here to add this to my saved trials
Phoenix, Arizona 85006
Principal Investigator: Allison Perrin, MD
Phone: 602-839-6900
Click here to add this to my saved trials